BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3884542)

  • 1. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
    Ahmed I; Patton TF
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
    Hämäläinen KM; Kananen K; Auriola S; Kontturi K; Urtti A
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):627-34. PubMed ID: 9071216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
    Ashton P; Podder SK; Lee VH
    Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application site dependent ocular absorption of timolol.
    Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
    J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.
    Ahmed I; Gokhale RD; Shah MV; Patton TF
    J Pharm Sci; 1987 Aug; 76(8):583-6. PubMed ID: 11002815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
    Chien DS; Homsy JJ; Gluchowski C; Tang-Liu DD
    Curr Eye Res; 1990 Nov; 9(11):1051-9. PubMed ID: 1982760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
    Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.
    Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2251-9. PubMed ID: 8505206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load.
    Chang SC; Bundgaard H; Buur A; Lee VH
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):487-91. PubMed ID: 3557861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits.
    Sasaki H; Ichikawa M; Kawakami S; Yamamura K; Mukai T; Nishida K; Nakamura J
    J Pharm Pharmacol; 1997 Feb; 49(2):140-4. PubMed ID: 9055184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
    Lee YH; Kompella UB; Lee VH
    Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs.
    Waltman SR; Kaufman HE
    Invest Ophthalmol; 1970 Apr; 9(4):250-5. PubMed ID: 5435768
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.
    Hosoya K; Lee VH; Kim KJ
    Eur J Pharm Biopharm; 2005 Jul; 60(2):227-40. PubMed ID: 15939235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the ocular bioavailability of timolol by sorbic acid.
    Higashiyama M; Inada K; Ohtori A; Tojo K
    Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.